Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient

Study Overview
=================
Brief Summary
-----------------
Measurement of disease control, treatment adherence and patient knowledge of his/her medication in patients that are receiving a pharmaceutical intervention compared with those patients who receive regular pharmaceutical care.

Official Title
-----------------
Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient

Conditions
-----------------
Asthma

Intervention / Treatment
-----------------
* Other: 1
* Other: 2


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients who have given their informed consent and expressed interest in participating in the study Asthmatic Patients Exclusion Criteria: Patients with communication difficulties. Persons who obtain symbicort but not for their own use. Patients with other major diseases: Heart problems, COPD, EMPHYSEMA, lung cancer, AIDS. Patients with a respiratory infection. Patients with seasonal asthma. Pregnant women Patients who have previously participated in a health education study in asthma.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| 1<br>1. Pilot Study: 60 patients (all in the intervention group) 30 patients with intervention A and 30 patients with B intervention) | Other: 1<br>* In the pilot study the objective is to compare 2 different pharmaceutical interventions (A and B) and to assess which one improves disease control, patient adherence and patient knowledge of the medication.<br>|
| 2<br>Main Study: 600 patients (30 pharmacies control group and 30 pharmacies intervention group, 10 patients per pharmacy) | Other: 2<br>* The best intervention used in the pilot study will be chosen and included in the main study.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluate the effect of the pharmaceutical intervention on the disease control, treatment adherence and patient knowledge of his/her medication using the MEF, treatment adherence and patient knowledge of the medication indicators. |  | First a Pilot in 3 months and then the final study in 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Compare disease control in patients who know their medication and those who doesn't. |  | First a Pilot in 3 months and then the final study in 6 months | 
| Compare disease control in patients who comply with their medication with those who doesn't. |  | First a Pilot in 3 months and then the final study in 6 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Asthma, Pharmaceutical intervention, Effect of a pharmaceutical intervention on the level of control of the asthmatic patient